Drug	Gene	Type	Source
Trilostane	FGF9	Text_Mining(affects(cotreatment))	CTD
Trilostane	FGF9	Text_Mining(decreases(reaction))	CTD
Trilostane	FGF9	Text_Mining(increases(abundance))	CTD
Trilostane	FSHB	Text_Mining(affects(cotreatment))	CTD
Trilostane	FSHB	Text_Mining(decreases(reaction))	CTD
Trilostane	FSHB	Text_Mining(increases(abundance))	CTD
Trilostane	IGF1	Text_Mining(affects(cotreatment))	CTD
Trilostane	IGF1	Text_Mining(decreases(reaction))	CTD
Trilostane	IGF1	Text_Mining(increases(abundance))	CTD
Trilostane	AR	Potency-Replicate_1=0.0531(uM)	D4 PubChem
Trilostane	AR	Ratio Potency (uM)=0.15089(uM)	D4 PubChem
Trilostane	AR	Ratio Potency (uM)=0.26499(uM)	D4 PubChem
Trilostane	AR	Potency-Replicate_1=1.5355(uM)	D4 PubChem
Trilostane	AR	Ratio Potency (uM)=28.613(uM)	D4 PubChem
Trilostane	ESR1	Potency-Replicate_1=16.7855(uM)	D4 PubChem
Trilostane	ESR1	Potency-Replicate_1=27.306(uM)	D4 PubChem
Trilostane	HSPB1	Ratio Potency (uM)=None(uM)	D4 PubChem
Trilostane	NFE2L2	Ratio Potency (uM)=22.8157(uM)	D4 PubChem
Trilostane	NFE2L2	Potency-Replicate_1=23.7083(uM)	D4 PubChem
Trilostane	NFE2L2	Ratio Potency (uM)=29.4844(uM)	D4 PubChem
Trilostane	NFE2L2	Potency-Replicate_1=30.6379(uM)	D4 PubChem
Trilostane	NR3C1	None=None(uM)	D4 PubChem